Fig. 5.
Overall survival from the time of inclusion in the LNH-87 trial of patients with ALCL according to the presence (n = 22) or absence (n = 124) of cutaneous involvement at the time of diagnosis. P = .0258.
Overall survival from the time of inclusion in the LNH-87 trial of patients with ALCL according to the presence (n = 22) or absence (n = 124) of cutaneous involvement at the time of diagnosis. P = .0258.
